Phannacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats
Open Access
- 1 January 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 99 (1) , 53-58
- https://doi.org/10.1111/j.1476-5381.1990.tb14653.x
Abstract
1 The purpose of this investigation was to examine in vivo drug-concentration anticonvulsant effect relationships of oxazepam in individual rats following administration of a single dose. 2 Whole blood concentration vs time profiles of oxazepam were determined following administration of doses of 4, 8 and 12 mg kg−1. The pharmacokinetics could be described by an open 2-compartment pharmacokinetic model. Following 12 mg kg−1 the values (mean ± s.e., n = 11) of clearance and volume of distribution were 28 ± 2 ml min−1 kg−1 and 2.6 ± 0.31 kg−1, respectively, and were not significantly different from the values obtained at the other doses. 3 The anticonvulsant effect was quantitated by a new technique which allows repetitive determination of the convulsive threshold by direct cortical stimulation within one rat. Significant dose-dependent elevations of the seizure threshold were observed. 4 By pharmacokinetic-pharmacodynamic modelling, a log-linear relationship was found between concentration and anticonvulsant effect. Following 12 mg kg−1 the values (mean ± s.e., n = 11) of the pharmacodynamic parameters slope and minimal effective concentration (Cmin) were 243 ± 27 μA and 0.11 ± 0.02 mg l−1, respectively and not significantly different from the values obtained at the other doses. 5 In a repeatability study the pharmacodynamic parameters were determined twice on two different occasions with an interval of two weeks in the same group of 11 rats. The inter-animal variability in the pharmacodynamic parameter slope was 46%, whereas the intra-animal variability was 24 ± 18%. The value of the minimal effective concentration was in each animal and on each occasion close to zero within the relatively narrow range of 0.01–0.30 mgl−1. 6 The results of this study showed that it is possible to determine in vivo concentration-anticonvulsant effect relationships of oxazepam under non-steady-state conditions in individual rats. The anti-convulsant effect of oxazepam appeared to be a rapidly reversible direct effect and acute tolerance did not develop within the time frame of the experiments.This publication has 21 references indexed in Scilit:
- Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: An overviewPharmacology & Therapeutics, 1988
- Strategy to Assess the Role of (Inter)active Metabolites in Pharmacodynamic Studies In-vivo: a Model Study with HeptabarbitalJournal of Pharmacy and Pharmacology, 1988
- Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measureJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Benzodiazepine Receptors and Their Relationship to the Treatment of EpilepsyEpilepsia, 1986
- Estimation of the blood-plasma concentration ratio of diazepam in the ratJournal of Pharmacokinetics and Biopharmaceutics, 1985
- Plasma concentrations of clobazam and its N-desmethyl metabolite; protection against pentetrazol-induced convulsions in miceJournal of Pharmacy and Pharmacology, 1984
- ELSMOS — an extended least squares modelling system in FORTRAN IV for mini- or micro-computer implementationComputer Programs in Biomedicine, 1984
- Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic modelJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and manJournal of Theoretical Biology, 1968